https://www.selleckchem.com/ph....armacological_epigen
Most participants either continued in ECT at the end of the study period or discontinued due to sustained remission. Limitations retrospective observational study without control group who did not receive ECT. Conclusions In this ECT cohort with at least 50 treatments, improvement in depression was sustained on QIDS and BASIS-24 and adverse cognitive effects were not detected by serial MoCAs, supporting the utility of maintenance ECT in this cohort.Background Augmentation therapies may be effective strategies to potentiate th
Curtir
Comentario
Compartilhar
